Pinnacle Information Blog
The content, articles and product information provided on this website are strictly educational and informational. They are intended to be used for in vitro research only. “In vitro” is a Latin phrase, “in glass,” that refers to research that is conducted outside of a living organism. Note, these products are not pharmaceuticals or medicines and have not been approved by the FDA for the diagnosis, treatment or prevention of any illnesses or disorders. These products are legally prohibited from human or animal consumption.
-
Posted: July 12, 2026Categories: Research PeptidesRead more »
GHRP-2 sits alongside GHRP-6 as one of the classic growth-hormone-releasing peptides, and it's often characterized in research as one of the more potent GH-releasers in the class. This overview covers what it is, how it works, how it compares to its siblings, and how to judge quality.
This article is for educational and research reference only. It is not medical advice, and Pinnacle materials are sold for laboratory and research use.
What GHRP-2 is
GHRP-2 is a growth-hormone-releasing peptide — a small synthetic peptide that stimulates growth hormone release via the ghrelin receptor (GHS-R), the same pathway as the rest of the GHRP class and distinct from the GHRH analogs.
How it works
GHRP-2 binds the GHS-R on the pituitary and prompts a pulse of growth hormone. In research it's noted as a potent GH-releaser. Because it acts on the ghrelin receptor, it produces some a
-
Posted: July 12, 2026Categories: Research PeptidesRead more »
GHRP-6 is one of the original growth-hormone-releasing peptides, and it's best known in research for a distinctive side effect: a strong stimulation of appetite. Understanding that trait is key to understanding how it differs from newer, more selective secretagogues. This overview covers what it is, how it works, how it compares to related peptides, and how to judge quality.
This article is for educational and research reference only. It is not medical advice, and Pinnacle materials are sold for laboratory and research use.
What GHRP-6 is
GHRP-6 is a growth-hormone-releasing peptide — a synthetic hexapeptide (six amino acids) that stimulates growth hormone release. Like the rest of the GHRP class, it works through the ghrelin receptor (the growth hormone secretagogue receptor, GHS-R), a different pathway from the GHRH analogs.
How it works
GHRP-6 binds the GHS-R and triggers a pulse of growth hormone. Because this is the ghrelin receptor — and ghrelin is the body's primary hunger signal — GHRP-6 also produces a pronounced appetite response in research models. That appetite effect is its signature and the main thing distinguishing it from the more selective peptides in the family.
GHRP-6 also tends to produce more off-target hormonal activity (such as cortisol and prolactin) than the newer, cleaner secretagogues. Growth hormone released this way drives IGF-1 downstream, as with the rest of the class
-
Posted: July 12, 2026Categories: Research PeptidesRead more »
Epithalon — also spelled Epitalon — is a short peptide that draws outsized interest because of its association with aging and telomere research. It's one of the more speculative compounds in the category, so separating the documented research from the extrapolation matters here more than most. This overview covers what it is, the mechanisms proposed, what studies exist, and how to judge quality.
This article is for educational and research reference only. It is not medical advice, and Pinnacle materials are sold for laboratory and research use.
What Epithalon is
Epithalon is a tetrapeptide — just four amino acids (Ala-Glu-Asp-Gly). It's a synthetic version of a peptide called epithalamin, which is associated with the pineal gland, the small brain structure that regulates melatonin and the body's circadian rhythms. Its short length and defined sequence make it a well-characterized molecule chemically, even where the b
-
Posted: July 12, 2026Categories: Research PeptidesRead more »
TB-500 shows up constantly in recovery-research discussions, usually next to BPC-157 — but there's a common point of confusion about what it actually is versus the natural peptide it's derived from. This overview clears that up and walks through the mechanism, the research, and how to judge quality.
This article is for educational and research reference only. It is not medical advice, and Pinnacle materials are sold for laboratory and research use.
What TB-500 is
TB-500 is a synthetic peptide based on the active region of Thymosin Beta-4 (TB4) — a naturally occurring peptide found throughout the body's tissues and involved in cell repair and migration. TB4 is the full natural molecule; TB-500 is a synthetic fragment corresponding to the part responsible for much of TB4's studied activity. They're related but not identical, and that distinction matters when reading research or evaluating a product.
How it's thought to work
-
Posted: July 12, 2026Categories: Research PeptidesRead more »
BPC-157 is one of the most talked-about peptides in the recovery and tissue-repair research space — and one where the online claims run well ahead of the published evidence. This overview covers what BPC-157 actually is, the mechanisms researchers have proposed, what the studies have examined, and how to tell a quality preparation from a marketing label.
This article is for educational and research reference only. It is not medical advice, and Pinnacle materials are sold for laboratory and research use.
What BPC-157 is
BPC stands for "Body Protection Compound." BPC-157 is a synthetic peptide — a chain of 15 amino acids — based on a partial sequence identified in a protein found in gastric juice. It doesn't exist as a standalone molecule in nature; it's a stable fragment engineered from that parent sequence, and its stability in the harsh environment of the stomach is part of what drew research attention.
How it's thought to work
Several mechanisms recur in the BPC-157 literature, and most of them center on tissue repair:
- Angiogenesis. A large share of the research points to BPC-157 promoting the formation of new blood vessels, partly through the VEGFR2 pathway. New vasculature is central to how tissue heals, which is the thread that ties most of its studied effects together.
- Growth-factor and fibroblast activity. Studies have looked at BPC-157's effect on fibroblasts — the cells that build tendon, ligament, and con
-
Posted: June 18, 2026Read more »
Retatrutide (MW 4731.3 g/mol, CAS 2381089-83-2) is a synthetic single-chain peptide that functions as a triple receptor agonist with activity at the GIP, GLP-1, and glucagon (GCG) receptors. It is supplied as a lyophilised white powder in a sterile glass vial containing 20mg of peptide. As a triple incretin/glucagon receptor research compound, Retatrutide requires careful reconstitution technique to preserve compound integrity across all three pharmacophore regions, achieve accurate working concentrations, and ensure reproducible results in comparative receptor pharmacology applications.
Unlike dual GIP/GLP-1 agonists, Retatrutide's additional glucagon-receptor activity makes it a valuable reference tool for studies dissecting how simultaneous engagement of three pathways differs from single- or dual-receptor activation in cell-based assay systems. Proper preparation is the foundation of attributable, reproducible data.
Materials Required
-
Posted: May 25, 2026Read more »
Ipamorelin is one of the most-studied growth-hormone-axis research peptides, and the question that comes up most is how it's "dosed" in the lab — meaning what working concentrations researchers actually use, and how to avoid the protocol mistakes that quietly ruin results. Here's a practical rundown.
What Ipamorelin Is
Ipamorelin is a selective GHSR-1a agonist — it acts on the growth-hormone-secretagogue receptor with high selectivity, which is exactly why it's valued as a research tool: it activates the GH-axis pathway cleanly, without the off-target activity of less-selective secretagogues. That selectivity makes it a clean comparator in cell-based GH-axis studies. You can source ipamorelin for research as a lyophilized powder.
Research "Dosing" — Working Concentration Ranges
In cell-based work, "dose" really means working concentration in the assay, not a per-day amount. Across GHSR-
-
Posted: April 13, 2026Read more »
How to Reconstitute Sermorelin + GHRP-6 Blend: Step-by-Step Lab Protocol
The Sermorelin + GHRP-6 Blend (2mg/2mg per vial) combines Sermorelin — the 29-amino acid GHRH(1-29)NH2 GHRH-R reference agonist — with GHRP-6, a first-generation GHSR-1a agonist, co-lyophilised in a single 10mL sterile glass vial. This blend supports comparative GH axis pharmacology research using native-sequence GHRH analogue (sermorelin) paired with GHSR-1a activation, providing mechanistically authentic upstream GH axis dual-receptor stimulation data.
Materials Required
- Sermorelin + GHRP-6 Blend 2mg/2mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
Pre-Reconstitution Preparation
Inspect the vial for intact lyophilised powder and unbroken seal. Allow to equilibrate to room tempe
-
Posted: April 13, 2026Read more »
How to Reconstitute CJC-1295 + Ipamorelin Blend: Laboratory Reconstitution Protocol
The CJC-1295 + Ipamorelin Blend (2mg/2mg per vial) combines CJC-1295 No DAC (GHRH-R agonist) and Ipamorelin (GHSR-1a agonist) co-lyophilised in a single 10mL sterile glass vial. This is the most commonly used dual GH axis blend in research settings due to ipamorelin's exceptional GHSR-1a selectivity, which produces clean, attributable receptor pharmacology data without the off-target corticotroph and lactotroph activity seen with GHRP-2 and GHRP-6.
Materials Required
- CJC-1295 + Ipamorelin Blend 2mg/2mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
Pre-Reconstitution Preparation
Inspect the vial for intact lyophilised powder and unbroken seal. Allow to equilibrate to room t
-
Posted: April 13, 2026Read more »
How to Reconstitute CJC-1295 + GHRP-6 Blend: Step-by-Step Lab Guide
The CJC-1295 + GHRP-6 Blend (2mg/2mg per vial) contains CJC-1295 No DAC (GHRH-R agonist) and GHRP-6 (GHSR-1a agonist) co-lyophilised in a single 10mL sterile glass vial. This blend provides simultaneous upstream GHRH-R and GHSR-1a receptor pathway activation in a single compound preparation, supporting dual-target GH axis research in pituitary somatotroph and GH axis cell model systems.
Materials Required
- CJC-1295 + GHRP-6 Blend 2mg/2mg lyophilised vial
- Bacteriostatic water (BAC water) — 10mL vial
- 1mL sterile syringe with needle
- Alcohol swabs (70% isopropyl)
- Nitrile gloves
- Permanent marker for labelling
Step-by-Step Reconstitution Protocol
Step 1 — Prepare workspace. Wipe work surface with 70% isopropyl alcohol. Allow to dry. Wear nitrile gloves.
Step 2 — Swab both stoppers.
